Brett R. Hagen, the Chief Accounting Officer of Allovir, Inc. (NASDAQ:ALVR), a company with a market capitalization of $49.2 ...

Miller Edward, General Counsel at Allovir, Inc. (NASDAQ:ALVR), recently sold shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The transactions, ...

EST AlloVir (ALVR) trading halted, news pendingStay Ahead of the Market:Discover outperforming stocks and invest smarter with Top Smart ...

AlloVir, Inc. (NASDAQ:ALVR), a biotechnology company specializing in biological products, announced today that it has completed a reverse stock split of its common stock at a 1-for-23 ratio.

What is the current share price of AlloVir Inc (ALVR)? AlloVir Inc's (ALVR) current share price is $9.28. This constitutes a price movement of 2,013.41% when compared to the share price 7 days ago and ...

AlloVir, Inc. (NASDAQ:ALVR), a biotechnology company specializing in biological products, announced today that it has completed a reverse stock split of its common stock at a 1-for-23 ratio. The move ...

In a recent development, AlloVir, Inc. (NASDAQ:ALVR), a company specializing in biological products currently trading at $0.45 per share, received approval from its shareholders for a reverse stock ...

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...

After Kalaris and AlloVir combine, the new company will have about $100 million to advance a treatment for age-related macular degeneration. As the U.S. stock market navigates a landscape shaped ...

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are ...